Attentional Impairment in People With Epilepsy
ETAPE
1 other identifier
observational
272
0 countries
N/A
Brief Summary
Epilepsy is one of the most common chronic neurological conditions.It leads to cognitive impairment in 20-50% of patients with a structural form. In comparison with seizures, these cognitive disorders are a major additional factor in occupational, social and family disability. They are particularly frequent (50%) in temporal epilepsies and preferably concern memory and language skills. The cognitive consequences of epilepsy are therefore well described in the following areas: episodic memory, language, executive functions. Concerning attentional abilities, a recent review has highlighted the lack of work in this specific field in order to properly measure the prevalence and nature of attentional disorders in epileptic patients. Indeed, attentional abilities are often mentioned in studies, but attention is a complex domain defined by four modalities: alertness, selective attention, divided attention and sustained attention. No study systematically assesses all of these modalities. The objective of this study is to evaluate the prevalence and nature of attentional disorders in epileptic patients compared to control subjects.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started May 2020
Longer than P75 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 27, 2020
CompletedStudy Start
First participant enrolled
May 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2020
CompletedFirst Posted
Study publicly available on registry
May 7, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2025
CompletedMay 7, 2020
April 1, 2020
Same day
April 27, 2020
May 6, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
d2-r
selective attention task
10 minutes
Secondary Outcomes (3)
sustained attention TAP Subtest
15 minutes
alertness attention TAP Subtest
8 minutes
divided attention TAP Subtest
5 minutes
Other Outcomes (6)
digit span
5 minutes
verbal fluency
5 minutes
incompatibility TAP subtest
8 minutes
- +3 more other outcomes
Study Arms (2)
patients with epilepsy
Attentional tasks : D2-R task and TAP battery (sustained attention, alertness, divided attention) executive task : digit span, incompatibility and flexibility task (TAP battery), verbal fluencies depression score (NDDI-E scale) and anxiety score (GAD-7 scale)
Normal controls
Attentional tasks : D2-R task and TAP battery (sustained attention, alertness, divided attention) executive task : digit span, incompatibility and flexibility task (TAP battery), verbal fluencies depression score (NDDI-E scale) and anxiety score (GAD-7 scale)
Interventions
a neuropsychological assessment of attentional task, executive task and interview is proposed to patients or normal control
Eligibility Criteria
people with epilepsy versus normal control
You may qualify if:
- Patient with epilepsy, according to Fisher et al. (2005).
- Patient with written informed consent
- affiliation to a social security regime is compulsory
- Individuals who have received full information about the organization of the research and have not objected to their participation and the use of their data.
- Patient 18 years of age and older
- Normal controls:
- Individuals who have received full information about the organization of the research and have not objected to their participation and the use of their data.
- People 18 years of age and older
- People with no neurological and/or psychiatric history
You may not qualify if:
- for patients: with another progressive neurological condition for all People of full age who are subject to a legal protection measure or who are unable to express their consent People deprived of their liberty by a judicial or administrative decision People who regularly use psychoactive substances (cannabis, alcohol...)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (1)
Brissart H, Forthoffer N, Maillard L. Attention disorders in adults with epilepsy. Determinants and therapeutic strategies. Rev Neurol (Paris). 2019 Mar;175(3):135-140. doi: 10.1016/j.neurol.2019.01.394. Epub 2019 Feb 28.
PMID: 30826090RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Day
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 27, 2020
First Posted
May 7, 2020
Study Start
May 1, 2020
Primary Completion
May 1, 2020
Study Completion
August 1, 2025
Last Updated
May 7, 2020
Record last verified: 2020-04
Data Sharing
- IPD Sharing
- Will not share